Pregnancy morbidity is one of the clinical manifestations used for classification criteria of
antiphospholipid syndrome (APS). During the 14th International Congress on …

There are multiple epidemiological studies that document the potential adverse affects of
autoimmunity on nearly every aspect of reproduction, even in the absence of clinically …

Annexin A5 (AnxA5) binds to phospholipid bilayers, forming two-dimensional crystals that
block the phospholipids from availability for coagulation enzyme reactions. Antiphospholipid …

Annexins are a group of 12 highly conserved proteins which exert several regulatory
functions on cell biology. There are involved in numerous cell processes including vesicle …

The phospholipid binding protein, annexin A5 (AnxA5), has potent anticoagulant properties
that result from its forming 2-dimensional crystals over phospholipids, blocking the …

Anti‐phospholipid syndrome (APS) recapitulates the link between autoimmunity and
pregnancy failure: Acquired anti‐phospholipid antibodies (aPL) play a pathogenic role in …

Both organ-specific and systemic autoimmunity are associated with an increased
prevalence of recurrent miscarriage (RM). The precise mechanism for this is unclear, as …

Evidence from basic science studies supports a causative relationship between
antiphospholipid antibodies (aPL) and recurrent early miscarriage (REM)(prior to 10 weeks …

Antiphospholipid syndrome (APS) is an autoimmune disease that is characterized by the
presence of thromboses and/or recurrent pregnancy losses (RPL). The persistent presence …

Several studies have been shown that Annexin V (ANXV) autoantibodies concentrations are
associated with both early recurrent pregnancy losses (RPLs) or in vitro fertilization failure …